EC Number | Application | Comment | Organism |
---|---|---|---|
3.1.3.48 | drug development | MptpB is a promising target for anti-tuberculosis drug development | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.3.48 | F1S-6C-W11 | - |
Mycobacterium tuberculosis | |
3.1.3.48 | H1-5C-W11 | - |
Mycobacterium tuberculosis | |
3.1.3.48 | additional information | PTP bidentate inhibitor library synthesis and screening, overview. The bidentate inhibitors have three components: 1. the warheads, alkyne-containing N-phenyloxamic acids that are cell-permeable, potent bioisosteric phosphotyrosine mimics, 2. a variety of different types of building blocks that act as the secondary-site binders, and 3. azide-containing linkers of different lengths joining the warhead and the building blocks, overview | Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.3.48 | Mycobacterium tuberculosis | - |
- |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.3.48 | More | the enzyme is a member of the PTP family | Mycobacterium tuberculosis |
3.1.3.48 | MPtpB | - |
Mycobacterium tuberculosis |
3.1.3.48 | protein tyrosine phosphatase B | - |
Mycobacterium tuberculosis |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.1.3.48 | 0.00015 | - |
F1S-6C-W11 | - |
Mycobacterium tuberculosis | |
3.1.3.48 | 0.00017 | - |
H1-5C-W11 | - |
Mycobacterium tuberculosis |